Galectins and Carcinogenesis: Their Role in Head and Neck Carcinomas and Thyroid Carcinomas

od Kindt, Nadège, Journe, Fabrice, Ghanem, Ghanem E., Saussez, Sven
Izdano u Int J Mol Sci (2017)

RTK Inhibitors in Melanoma: From Bench to Bedside

od Sabbah, Malak, Najem, Ahmad, Krayem, Mohammad, Awada, Ahmad, Journe, Fabrice, Ghanem, Ghanem E.
Izdano u Cancers (Basel) (2021)

Acquired resistance to BRAFi reverses senescence-like phenotype in mutant BRAF melanoma

od Krayem, Mohammad, Najem, Ahmad, Journe, Fabrice, Morandini, Renato, Sales, François, Awada, Ahmad, Ghanem, Ghanem E.
Izdano u Oncotarget (2018)

Metabolic Reprogramming in Metastatic Melanoma with Acquired Resistance to Targeted Therapies: Integrative Metabolomic and Proteomic Analysis

od Soumoy, Laura, Schepkens, Corentin, Krayem, Mohammad, Najem, Ahmad, Tagliatti, Vanessa, Ghanem, Ghanem E., Saussez, Sven, Colet, Jean-Marie, Journe, Fabrice
Izdano u Cancers (Basel) (2020)

The Benefit of Reactivating p53 under MAPK Inhibition on the Efficacy of Radiotherapy in Melanoma

od Krayem, Mohammad, Sabbah, Malak, Najem, Ahmad, Wouters, An, Lardon, Filip, Simon, Stephane, Sales, François, Journe, Fabrice, Awada, Ahmad, Ghanem, Ghanem E., Van Gestel, Dirk
Izdano u Cancers (Basel) (2019)

FGF2 Induces Resistance to Nilotinib through MAPK Pathway Activation in KIT Mutated Melanoma

od Tétu, Pauline, Delyon, Julie, André, Jocelyne, Reger de Moura, Coralie, Sabbah, Malak, Ghanem, Ghanem E, Battistella, Maxime, Mourah, Samia, Lebbé, Céleste, Dumaz, Nicolas
Izdano u Cancers (Basel) (2020)

Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance Short Title: Sensitivity Pre...

od Krayem, Mohamad, Aftimos, Philippe, Najem, Ahmad, van den Hooven, Tim, van den Berg, Adriënne, Hovestad-Bijl, Liesbeth, de Wijn, Rik, Hilhorst, Riet, Ruijtenbeek, Rob, Sabbah, Malak, Kerger, Joseph, Awada, Ahmad, Journe, Fabrice, Ghanem, Ghanem E.
Izdano u Cancers (Basel) (2020)

Erratum: Krayem, M., et al. Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance S...

od Krayem, Mohammad, Aftimos, Philippe, Najem, Ahmad, van den Hooven, Tim, van den Berg, Adriënne, Hovestad-Bijl, Liesbeth, de Wijn, Rik, Hilhorst, Riet, Ruijtenbeek, Rob, Sabbah, Malak, Kerger, Joseph, Awada, Ahmad, Journe, Fabrice, Ghanem, Ghanem E.
Izdano u Cancers (Basel) (2020)

MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma

od Zhan, Yao, Guo, Jun, Yang, William, Goncalves, Christophe, Rzymski, Tomasz, Dreas, Agnieszka, Żyłkiewicz, Eliza, Mikulski, Maciej, Brzózka, Krzysztof, Golas, Aniela, Kong, Yan, Ma, Meng, Huang, Fan, Huor, Bonnie, Guo, Qianyu, da Silva, Sabrina Daniela, Torres, Jose, Cai, Yutian, Topisirovic, Ivan, Su, Jie, Bijian, Krikor, Alaoui-Jamali, Moulay A., Huang, Sidong, Journe, Fabrice, Ghanem, Ghanem E., Miller, Wilson H., del Rincón, Sonia V.
Izdano u J Clin Invest (2017)

Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses

od Huang, Fan, Gonçalves, Christophe, Bartish, Margarita, Rémy-Sarrazin, Joelle, Issa, Mark E., Cordeiro, Brendan, Guo, Qianyu, Emond, Audrey, Attias, Mikhael, Yang, William, Plourde, Dany, Su, Jie, Gimeno, Marina Godoy, Zhan, Yao, Galán, Alba, Rzymski, Tomasz, Mazan, Milena, Masiejczyk, Magdalena, Faber, Jacek, Khoury, Elie, Benoit, Alexandre, Gagnon, Natascha, Dankort, David, Journe, Fabrice, Ghanem, Ghanem E., Krawczyk, Connie M., Saragovi, H. Uri, Piccirillo, Ciriaco A., Sonenberg, Nahum, Topisirovic, Ivan, Rudd, Christopher E., Miller, Wilson H., del Rincón, Sonia V.
Izdano u J Clin Invest (2021)